- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
The European Union could pay more than USD 10 billion to secure hundreds of millions of doses of the vaccines being developed by Pfizer-BioNTech and CureVac, an EU official told Reuters. The bloc has agreed to pay 15.50 euros per dose for the Pfizer vaccine giving an overall price of up to 3.1 billion euros for 200 million doses, rising to 4.65 billion euros if another optional 100 million doses are purchased under the deal.
The EU has separately agreed to pay 10 euros per dose for an initial supply of 225 million doses of the CureVac vaccine, a discount from the 12 euros the company had set as the price. The Curevac deal secured up to 405 million doses, of which 180 million are optional
CureVac had committed to start delivery by the end of March 2021.
Countering Misinformation & Disinformation: Practical Training for Organizations
Practical skills to detect, verify, and respond across an evolving information landscape
Additional data provided by
English
Japanese
